BMO downgrades RXO stock rating on merger agreement terms
Covered in this story
Tracked from this story
BMO Capital Markets’s $30.3 target on $RXO is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
BMO Capital Markets’s track record →Analyst targets on Rxo Inc
- JPMorgan: $28.6 → $30 by Oct 2027 · Neutral via Investing.com
- TD Cowen: $28.6 → $30.3 by Oct 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $RXO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Rxo Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.